Tioga Pharmaceuticals Secures $18,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=97a7e489-95ee-4ee9-aac9-5bff2b0d56ee&Preview=1 -
Date
2/17/2010 -
Company Name
Tioga Pharmaceuticals -
Mailing Address
9393 Towne Centre Dr. San Diego, CA 92121 -
Company Description
Tioga Pharmaceuticals is engaged in the development of novel therapies for the treatment of gastrointestinal diseases. Tioga is developing asimadoline, a proprietary small molecule, for treating irritable bowel syndrome (IBS) and post operative ileus. -
Website
http://www.tiogapharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$18,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The proceeds will be used to fund a Phase 3 clinical trial for asimadoline for the treatment of patients with diarrhea predominant Irritable Bowel Syndrome (D-IBS). -
M&A Terms
-
Venture Investor
Forward Ventures -
Venture Investor
New Leaf Venture Partners -
Venture Investor
BB Biotech Ventures -
Venture Investor
Genesys Capital
